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Abstract 
Pancreatic adenocarcinoma cell lines rarely express the CFTR gene, despite the high levels of CFFR protein that are present in 
primary pancreatic duct cells. We have attempted to generate a non-CF pancreatic adenocarcinoma cell line that stably produces high 
levels of CFTR mRNA and protein by transfecting a vector containing the CFTR cDNA, driven by a strong mammalian promoter, into 
the poorly differentiated pancreatic adenocarcinoma cell line, Panc-1. The pANS6 pancreatic duct cell line expresses substantial levels of 
CFTR mRNA, but little CFTR protein. Despite this we were able to detect low conductance chloride channels in 40% of patches, 
stimulated with cAMP, that have similar biophysical properties to CFTR. 
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1. Introduction 
One of the diagnostic features of the autosomal reces- 
sive disease cystic fibrosis is the destruction of the pan- 
creas. Pancreatic ducts become obstructed from the mid 
trimester of development [1], causing gradual autolysis of 
acini and their replacement by cystic spaces. As a result 
more than 85% of CF patients show pancreatic insuffi- 
ciency. The isolation of the cystic fibrosis transmembrane 
conductance regulator (CFTR) gene [2,3] and the charac- 
terization of the CFTR protein as a cAMP-activated small 
conductance chloride channel [4-9] have not fully ex- 
plained the pancreatic CF pathology. The definition of 
mutations in the CFTR gene has suggested that though the 
most common mutation (AF508) [ 10] is usually associated 
with pancreatic insufficiency, there are a group of other 
mutations that are associated with some limited pancreatic 
function [ 11 ]. 
Pancreatic duct cells express very high levels of CFTR 
mRNA and protein in vivo [12-15]. In order to investigate 
further the effects of mutations in the CFTR gene on the 
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function of pancreatic duct cells we have analyzed a large 
number of pancreatic adenocarcinoma cell lines, that are 
usually ductal in origin, to look for CFI'R expression [16]. 
Surprisingly, only two cell lines were found to express 
CFTR mRNA and only one of these, Capan 1 [17] at a 
level comparable to some primary cultures of ductal ep- 
ithelial cells. This is in marked contrast o several colon 
carcinoma cell lines that express very high levels of CFTR, 
these cell lines arising from colonic crypt epithelial cells 
that are another site of high level CFTR expression in vivo 
[12-15]. 
Due to the paucity of pancreatic', cell lines expressing 
CFFR we have attempted to generate a non-CF pancreatic 
adenocarcinoma cell line that stably produces high levels 
of CFTR mRNA and protein. A CFTR transfected CF 
pancreatic adenocarcinoma cell line CFPAC [18] has been 
previously generated by others using retrovirus-mediated 
gene transfer [19,20]. The approach used here has been to 
transfect a vector containing the CFTR cDNA (driven by a 
strong mammalian promoter) and a ~;electable marker gene 
into a poorly differentiated pancreatic adenocarcinoma cell 
line. The cell line used was Panc-! [21,22] which does not 
express CFTR endogenously and the vector used was 
pH/3APr-l-neo that employs the human /3 actin promoter 
and contains a neomycin resistance cassette [23]. This 
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vector system has been used to effectively generate 
Pancl-derived pancreatic duct cell lines overexpressing the 
MUC1 mucin [24]. We have generated a pancreatic duct 
cell line that expresses substantial levels of CFTR mRNA 
but little CFTR protein and a cAMP-activated chloride 
channel that has similar biophysical properties to CFTR. 
2. Materials and methods 
concentration of a 3' primer homologous to the house- 
keeping gene glucocerebrosidase in the same tube. The 3' 
primers were annealed to 1 ~g of total RNA from the cell 
line of interest at 65°C for 10 rain and used to prime 
cDNA synthesis from each gene at 42°C for 60 min with 
reverse transcriptase (BRL). The PCR reaction for CPTR 
was 94 °C for 5 rain, then 30 cycles of 93°C for 1 min, 
60°C for 1 min and 72°C for 5 rain, with a final elonga- 
tion step of 72 ° C for 5 min. 
2.1. Construction of pans expression vector 2.4. Northern blot hybridisation 
The pH/3 APr-1-neo mammalian expression vector was 
kindly donated by Dr L. Kedes. The full length CFTR 
cDNA clone pCOF was kindly donated by Drs J. Rom- 
mens and L.-C. Tsui [25]. This cDNA clone contains three 
silent nucleotide substitutions to abolish the cryptic bacte- 
rial promoter in exon 6b. The CFTR cDNA was excised 
from pCOF as overlapping Ncol and Sphl to Sall frag- 
ments. The ends of the Ncol fragment were filled in using 
Klenow polymerase and ligated to a phosphorylated linker 
containing a Sall site (5'pGTGGTCGACCAC 3'). This 
fragment was then cleaved with Sall and Sphl and the 1.7 
kb product ligated to the 4.5 kb Sphl/Sal l  fragment and 
Sall cleaved, dephosphorylated pH/3 APr-i-neo. All re- 
striction and ligation sites were sequenced to confirm that 
no mutations had been generated in the CFTR cDNA 
during cloning. 
2.2. Cell culture and transfections 
The Panc-I cell line was grown in Dulbecco's modified 
Eagle's medium supplemented with 10% foetal calf serum, 
2 mM L-glutamine, 100 U/ml  penicillin, 100 /zg/ml 
streptomycin (all from Gibco). 90 mm plates of approx. 
30% confluent cells were transfected using a standard 
CaPO 4 procedure. 4 h prior to transfection the culture 
media was replaced. A solution of t0 /zg  plasmid DNA in 
100 /zl TE (10 mM Tris-HCl (pH 7.5), 1 mM EDTA (pH 
7.5))/300 /zl 25 mM Hepes (pH 7.3)/100 /zl (1.25 M 
CaC! 2, 0.125 M Hepes) was added dropwise to 500 /zl 
(280 mM NaCI, 1.5 mM Na2HPO 4. 12H20, 25 mM 
Hepes (pH 7.3)) and incubated at room temperature for 30 
rain. The DNA-CaPO 4 precipitate was then added to the 
culture medium and incubated at 37°C for 6 h. G418 
selection (0.3 mg/ml)  was commenced 48 h post transfec- 
tion. Transfectant colonies were isolated 3 weeks post 
transfection and analysed further. 
2.3. Reverse transcriptase-PCR 
Total cellular RNA was prepared by the method of 
Chirgwin et al. [26]. Reverse-transcriptase-PCR (RT-PCR) 
was carried out as described previously [16]. Briefly, for 
each reaction, cDNA was synthesized using the 3' primer 
of the CFTR gene fragment, together with 1/10th the 
Total cellular RNA was prepared by the method of 
Chirgwin et al. [26]. 20 /zg of total RNA was elec- 
trophoresed through a 1.35% agarose/formaldehyde gel 
and transferred to a Hybond N membrane. The C l -1 /5  
CFTR cDNA [2] fragment was labelled with [a-32 P]dCTP 
using the Megaprime Kit (Amersham). The membrane was 
hybridised at 42 ° C for 18 h in 50% formamide, 4 x SSC, 
10×Denhardts, 1% SDS, 10% dextran sulphate, 200 
/xg/ml salmon sperm DNA and washed to a stringency of 
1 X SSC, 1% SDS at 65 ° C, prior to exposure to Hyperfilm 
MP before autoradiography. After stripping the blot was 
subsequently probed with a 300 bp probe for human 
glyceraldehyde 3 phosphate dehydrogenase, to quantify 
total RNA levels in each lane. 
2.5. Western blotting 
Confluent cell monolayers were washed in ice cold PBS 
and scraped into a solution of 10 mM Tris-HC1 (pH 8.0), 
10 mM KC1, 1.5 mM MgC12 plus protease inhibitors 
(aprotinin 10 /zg/ml, EDTA 0.5 raM, benzamidine 2 mM, 
antipain 50 /xg/ml, leupeptin 5 /zg/ml, pepstatin A 5 
/zg/ml, PMSF 1 raM). The cell lysate was passed through 
a 19 gauge needle 10-15 times and spun at 250 X g for 5 
min at 4 ° C. The supernatant was spun at 70000 X g for 
30 min at 4 ° C. The resulting protein pellet was solubilized 
in 2% Triton X-100 and mixed with an equal volume of 
2 × sample buffer (0.06 M Tris-HC1 (pH 6.8), 2% SDS, 
10% glycerol, 0.025% bromophenol b ue). The sample was 
incubated at 37°C for 10 min before loading onto a 6% 
SDS-PAGE gel. Gels were run and blotted onto Hybond-C 
super nitrocellulose in a Bio-Rad mini-protean II appara- 
tus. Western filters were probed with the anti-CFTR rabbit 
polyclonal antibody 181 (kindly supplied by Dr I. Craw- 
ford) or 24-1 (kindly supplied by Dr. S. Cheng, Genzyme) 
using the ECL detection system (Amersham). 
2.6. Electrophysiological experiments 
Full details of the electrophysiological techniques used 
in this study are described elsewhere [9,27,28]. Glass 
coverslips forming the culture substrate were placed in a 
tissue bath (volume 1.5 ml) mounted on a Nikon Diaphot 
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inverted microscope (Nikon, UK), and viewed using 
phase-contrast optics. Single channel current recordings 
from cell-attached membrane patches were made at 21- 
23 ° C, using the patch-clamp technique. Recording pipettes 
were constructed from 1.2 mm o.d. borosilicate glass 
(Clarke Electromedical, UK) and had resistances of be- 
tween 4-10 M/2 after fire polishing. Seal resistances were 
between 10-30 G~Q. Single-channel currents were ampli- 
fied using an EPC-7 patch-clamp amplifier (List Elec- 
tronic, Darmstadt) and stored on a digital tape recorder. 
For viewing and analysis these data were low-pass filtered 
at 100 Hz (Frequency Devices) and displayed on a digital 
storage oscilloscope (Gould, UK). Permanent records were 
made using a graphics plotter (Hewlett Packard). Junction 
potentials were measured using a flowing 3 M-KC1 elec- 
trode, and the appropriate corrections were applied to our 
data. The tissue bath was grounded and the potential 
difference referenced to the extracellular face of the mem- 
brane. In the cell-attached configuration, the potential dif- 
ference across the patch is equal to the cell membrane 
potential minus the pipette clamp potential (Vv). Because 
the membrane potential is unknown, we give Vp values in 
this recording configuration. Outward current, the flow of 
positive charge from the inside to the outside of the 
membrane, is indicated as an upward deflection on all the 
records. Reversal potentials (Ere,,) were obtained from 
interpolation of I-V plots after fitting a second order 
polynomial using least squares regression analysis and we 
give chord conductances between E,.~v and _+60 inV. To 
determine the open state probability (Po), current records 
were digitized at 2 kHz using a CED 1401 interface 
(Cambridge Electronic Design, UK) and analysed using a 
two threshold transition algorithm which used a 50% 
threshold crossing parameter to detect events. Po was 
calculated as the traction of total time that channels were 
open using a minimum of 60 s of data. When multi-chan- 
nel patches were used for these determinations, we as- 
sumed that the total number of channels present was equal 
to the maximum number of simultaneous current transi- 
tions. 
The cells were perfused externally with a sodium-rich 
extracellular solution which contained (in mM) 138.0 NaC1, 
4.5 KC1, 2.0 CaCI 2, 1.0 MgC12, 5.0 Glucose, and 10 
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
(Hepes), pH 7.4. The pipette solution was filtered through 
a 0.2 /xM membrane filter and contained (in mM) either 
135 CsC1, 135 tetraethylammonium chloride (TEA-C1), or 
135 N-methyl-D-glucamine chloride (NMDG-CI), 2.0 
MgC12, 2.0 EGTA, 10 Hepes, 1 ATP, pH 7.2. To deter- 
mine the selectivity of the currents, 100 mM chloride in 
the pipette solution was replaced with gluconate. This 
pipette solution contained (in raM) 38.0 NaCI, 100 Na 
gluconate, 4.5 KCI, I MgC12, 2 CaCI 2, 10.0 Hepes, pH 
7.4. The cells were prestimulated with a cAMP cocktail 
which contained 1 #M Forskolin, 0. l mM dibutyryl cAMP, 
and 0.1 mM 3-isobutyl- 1-methylxanthine. 
3. Results 
3.1. Analysis of transfected cell line~ 
17 G418-resistant clones of Panc-1 transfected with the 
pANS vector and 13 clones, transfected with the pH/3 
APr-l-neo vector, were isolated and screened for the ex- 
pression of CFTR mRNA by reverse transcriptase (RT)- 
PCR (not shown) and Northern blot analysis. Fig. 1 shows 
a Northern blot of 2 vector only cell lines and the 6 
pANS-transfected Panc-1 cell lines that appeared to show 
highest levels of expression of the CFTR gene on RT-PCR 
analysis, probed with the C1-1/5 CFTR cDNA probe that 
includes exons 9-24 of CFTR. No CFTR expression was 
seen in Panc-I cells (not shown) or in the LK1 and LK2 
vector-only controls. The pANS 4, 6 and 12 cell lines all 
express substantial amounts of the 6.5 kb CFTR mRNA, 
equivalent o the full length CFTR transcript seen in the 
HT29 colon carcinoma cell line that expresses high levels 
of endogenous CFTR mRNA. The pANS 7 cell line ex- 
presses lower levels of CFTR mRNA. Additional larger 
mRNA species that hybridize to the CFTR cDNA probe 
are also seen in pANS 4, 6 and 12 cells lines. This 
phenomenon has been observed by others and is probably 
due to use of alternative polyadenylation sites [25]. 
3.2. Protein analysis 
Despite the abundance of CFTR tcanscripts in the pANS 
4, 6 and 12 cell lines we were unable to detect substantial 
expression of CFTR protein by western blot analysis, 
under conditions where CFTR protein was clearly de- 
tectable in HT 29 cells (not shown). 
3.3. Electrophysiological analysis 
In preliminary experiments he pANS 4, 6 and 7 clones 
together with three vector only clones, LK1, 2 and 9, were 
LK P.Z~qS H'I29 
CFFR • 
1 2 4 6 7 12 17 18 
iiii::: 
GAPDH . . . . .  
Fig. I. Autoradiograph of a Northern blot of 10 p,g of total RNA from 2 
vector only Panc-l transfectants and 6 pANS-transfected Panc-l cell 
lines, (a) probed with the C l - I /5  CFTR cDNA probe that includes exons 
9-24 of the CFTR cDNA, (b) probed with a partial cDNA for human 
glyceraldehyde phosphate dehydrogenase. 
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Fig. 2. The small-conductance channel in cell-attached patches. (A) Typical current races recorded at the pipette potentials (Vp) indicated. Dashed lines 
show current level when all channels are closed. Solutions: bath, Na-rich; pipette 135 TEA. (B) Single channel I \V  plot with Na-rich solution in the bath 
and one of three cations in the pipette. Data are from 9 patches on 9 different cells with either 135 CsC1 (n = 4), 135 TEA (n = 3), or 135 NMDG (n = 2) 
in the pipette. Current records have been low-pass filtered at 100 Hz. The line was fitted by a second-order polynomial least squares regression analysis. 
assayed for cAMP-activated iodide effiux. The pANS 6 
clone alone showed a small cAMP-induced iodide effiux 
(data not shown). This clone was thus analysed further by 
the patch clamp technique. In pANS6 cells that were not 
exposed to a cAMP cocktail we were unable to detect any 
small, single channel, CFTR-Iike currents (0/15). If, how- 
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Fig. 3. Chloride selectivity of the small-conductance channel. (A) Typical single channel currents recorded at the pipette potentials (Vp) indicated, after 
substituting 100 mM CI in the recording pipette with gluconate. Dashed lines show current level when all channels are closed. The bath solution was 
Na-rich. (B) I \V  plot. Bath, Na-rich; pipette, gluconate replacement. Data was obtained from 6 patches from 6 different cells. The line was fitted by a 
second-order polynomial least squares regression analysis. 
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ever, the cells were prestimulated with the cAMP cocktail 
for 0.5-6 h before patching we did detect CFTR-Iike 
channel activity in 40% of cell-attached patches (10/25). 
Fig. 2A shows single channel activity recorded from a 
cell-attached patch that contained one active channel. When 
this patch was depolarised the channel exhibited slow 
kinetics with open and closed times of the order of hun- 
dreds of msec; however, rapid closing events appeared 
when the patch was hyperpolarised and inward currents 
were flowing through the channel. The I /V  plot of the 
channel in cell-attached patches showed slight outward 
rectification (see Fig. 2B), the conductance being 6.2 pS 
for outward current and 4.8 pS for inward current. Fig. 2B 
also shows that the unitary currents reversed at Vp = 
-8 .9mV and that similar results were obtained whether 
the pipette solution contained CsCI (n = 4), TEA-C1 (n = 
3), or NMDG-C1 (n = 2). 
We tested for chloride selectivity of the low conduc- 
tance channel in cell-attached patches by replacing 100 
mM C1 in the pipette solution with gluconate. If the 
channel selects for chloride over gluconate then this ma- 
noeuvre will cause a negative (rightward) shift in the 
single channel current reversal potential. Fig. 3A and B 
shows that replacing 100 mM chloride in the pipette 
solution with gluconate caused the reversal potential to 
shift by - 17.2 mV ( -8 .9  mV to -26.1 mV). These data 
confirm that the low conductance channel is chloride 
selective. Low conductance channels were observed in 
35% of cell-attached patches (6/17) when using the low 
CI pipette solution. The average number of channels per 
patch for all channel bearing patches from which data was 
obtained was 2.7_+0.4; n= 15 (range 1-7 channels). 
Further evidence that the single channel currents we ob- 
served were similar to CFTR was obtained from an analy- 
sis of the open state probability (Po). We carried out Po 
analysis on 8 different patches, from experiments using 
both TEA and gluconate-replacement pipette solutions. 
Fig. 4 summarizes this data and shows that Po varied 
between 0.1-0.3 (mean Po = 0.16 + 0.02, from 11 Vp val- 
0.5 
o la. • 
0 , . . . .  r . . . .  i , 
100 0 -100 
Vp (mY] 
Fig. 4. Effect of pipette potential (Vp) on the open state probability (Po) 
of the small conductance CI- channel incell-attached patches. Data from 
8 patches obtained from different cells; 5 with gluconate in the pipette 
solution and 3 with TEA-C1 in the pipette solution. 
ues) and did not show any voltage dependence over the 
pipette potential range of _+ 100 mV. Taken together the 
above data suggests that the cAMP-stimulated channels we 
observed in cultures of transfected pANS6 was carried by 
the CFTR chloride channel. 
We also looked for CFTR channels in cultures of LK9 
and LK10 clones. However, even after prestimulating the 
cells with the cAMP cocktail for 0.5 to 6 hrs we were 
unable to detect any CFTR-like currents in cell-attached 
patches obtained from these cells (0/15). 
4. Discussion 
We describe a Pancl-derived cell line, pANS 6, that has 
been transfected with a vector that is capable of driving 
high level expression of CFTR mRNA. The pANS 6 cell 
line expresses a cAMP-activated chloride ion channel that 
appears similar to the CFTR channel that has been de- 
scribed in primary epithelial cell lines [9,27-29,3 t] and in 
cell lines transfected with the CFTR gene [4-7,20,30]. The 
channel was present in 35-40% of stimulated cell-attached 
patches and had a slightly outwardly rectifying I /V  plot. 
The chord conductance of the channel was 6.2 pS (out- 
ward) and 4.8 pS (inward) and the channel was shown to 
be chloride selective. The outwardly rectifying I /V  curve 
for the single channel currents reversed at -8 .9  mV, 
suggesting that chloride is accumulated above electro- 
chemical equilibrium in pANS6 cells. The above results 
are similar to those reported previously for several pancre- 
atic ductal preparations where dam for comparison are 
available [9,20,29,30]. One difference, however, lies in the 
Po of the channel. The Po of 0.16 is significantly different 
(P < 0.003) to the values reported in human fetal pancre- 
atic ducts of 0.31 ± 0.04 [9] and CPTR-transfected CHO 
cells of 0.41 + 0.02 [30] and reduced compared to the 
value of Capan-I cells of 0.60_+ G.3 [29]. The average 
number of channels per patch from cAMP-stimulated cells 
however, is similar to earlier reports [9,29]. The reason for 
this low Po is unclear, but it does suggest hat the regula- 
tion of the CFTR channel may be affected. The vector-only 
transfectants, and the Panc-1 parental cell line showed no 
CFTR-Iike single channels, an observation supported by 
lack of CFTR mRNA in these cells as assayed by the 
sensitive reverse transcriptase-PCR technique [16]. 
The reason for the very low levels of CFTR protein in 
the pANS 6 cell line is unclear but the electophysiological 
data suggest hat very small amount:~ of functional CFTR 
protein may be required to generate ffective CFTR chlo- 
ride channels. Three Pancl-derived cell lines pANS 4, 6, 
and 12 were seen to be transcribing abundant levels of 
CFTR mRNA as would be expected from the /3 actin 
promoter in the pH/3 APr-l-neo vector. However, this 
mRNA did not produce large amounls of functional CFTR 
protein. It is possible that during the cloning of the CFTR 
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cDNA into the pH/3 APr-1-neo expression vector we have 
inadvertently introduced a mutation into the CFTR cDNA. 
However, we have carried out sequence analysis to show 
that regions of the cDNA which have been cleaved and 
relegated o not carry any mutations. It is also possible 
that during propagation of the pANS plasmid a mutation 
occurred in the CFTR cDNA which is known to be 
relatively unstable in bacterial systems. This will only be 
revealed by sequencing the whole 6.2 kb CFTR cDNA in 
the pANS vector. 
A final possibility is that the PANC-I cell line itself 
contains factors that prevent high level expression of CFTR 
protein. This would be of particular interest in the context 
of the observation that the vast majority of pancreatic 
adenocarcinoma cell lines, that are derived from pancreatic 
duct epithelial cells which express CFTR at high levels in 
vivo, have switched off CFTR expression [16]. The fact 
that the CFTR cDNA construct that we have used in these 
experiments includes most of the 3' untranslated portion of 
the CFTR mRNA may be of relevance. It is possible that 
some pancreatic adenocarcinoma cell lines contain proteins 
that are capable of causing post-transcriptional or post- 
translational effects on the CFTR mRNA or CFTR protein 
inhibiting synthesis of a functional CFTR protein despite 
the presence of abundant CFTR mRNA. 
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